Back to Search Start Over

Discovery of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold.

Authors :
Yu W
Deng Y
Sloman D
Li D
Liu K
Fradera X
Lesburg CA
Martinot T
Doty A
Ferguson H
Richard Miller J
Knemeyer I
Otte K
Vincent S
Sciammetta N
Jonathan Bennett D
Han Y
Source :
Bioorganic & medicinal chemistry letters [Bioorg Med Chem Lett] 2021 Oct 01; Vol. 49, pp. 128314. Date of Electronic Publication: 2021 Aug 13.
Publication Year :
2021

Abstract

A series of IDO1 inhibitors containing a decahydroquinoline, decahydro-1,6-naphthyridine, or octahydro-1H-pyrrolo[3,2-c]pyridine scaffold were identified with good cellular and human whole blood activity against IDO1. These inhibitors contain multiple chiral centers and all diastereomers were separated. The absolute stereochemistry of each isomers were not determined. Compounds 15 and 27 stood out as leads due to their good cellular as well as human whole blood IDO1 inhibition activity, low unbound clearance, and reasonable mean residence time in rat cassette PK studies.<br /> (Copyright © 2021 Elsevier Ltd. All rights reserved.)

Details

Language :
English
ISSN :
1464-3405
Volume :
49
Database :
MEDLINE
Journal :
Bioorganic & medicinal chemistry letters
Publication Type :
Academic Journal
Accession number :
34391891
Full Text :
https://doi.org/10.1016/j.bmcl.2021.128314